Bard Gets Fed. Circ. To Revive $68M Infringement Trial
A Delaware federal judge made several mistakes when he stopped an infringement trial with $67.5 million on the line to conclude medical device maker C.R. Bard's patent claims were invalid and...To view the full article, register now.
Already a subscriber? Click here to view full article